Sharescart Research Club logo

Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
₹1417 Cr.
Stock P/E
-60.5
P/B
1.8
Current Price
₹277
Book Value
₹ 154
Face Value
10
52W High
₹353.5
52W Low
₹ 227.7
Dividend Yield
0%

Godavari Biorefin Overview

Business

Godavari Biorefineries Ltd. (GBL) is an integrated bio-refinery company in India, primarily involved in the processing of sugarcane. Its core business extends beyond conventional sugar production to leverage various by-products for diversified revenue streams. This includes the manufacturing of crystal sugar, ethanol (from molasses), co-generation of power (from bagasse), and the production of specialty chemicals such as industrial alcohol, rectified spirit, extra neutral alcohol, and other value-added chemicals derived from biomass. The "biorefineries" aspect signifies its focus on converting renewable resources into various fuels, chemicals, and sugar, thereby maximizing resource utilization and reducing dependence solely on sugar commodity prices. The company generates revenue through the sale of these various products to industrial, commercial, and consumer markets.

Revenue Mix

While specific revenue percentages are not available, Godavari Biorefineries typically operates across the following key segments:

Sugar: Production and sale of crystal sugar for domestic consumption and export.

Biofuels (Ethanol): Manufacturing and sale of ethanol, primarily supplied for blending with petrol as per government mandates.

Power Co-generation: Generation and sale of electricity using bagasse (a fibrous residue of sugarcane) as fuel.

Specialty Chemicals: Production of various alcohol-based chemicals, rectified spirits, and other derivatives used in industries such as pharmaceuticals, distilleries, and as industrial solvents.

This integrated model aims to mitigate risks associated with the cyclical nature of the sugar industry by diversifying its product portfolio.

Industry

The Indian sugar industry is highly regulated, cyclical, and significantly influenced by monsoon patterns and sugarcane cultivation. It is characterized by numerous players, many of whom are integrated sugar mills. Godavari Biorefineries positions itself as an integrated bio-refinery, distinguishing itself by moving beyond traditional sugar production into higher-value and diversified products like ethanol and specialty chemicals. This diversification offers a degree of insulation from the inherent volatility of sugar prices and allows the company to capitalize on the growing demand for biofuels and biochemicals. Its positioning is among the established medium-to-large scale players within India's sugar and bio-products sector, with a strategic emphasis on value addition and sustainability.

MOAT

Integrated Operations and Diversification: By efficiently converting sugarcane into multiple products (sugar, ethanol, power, chemicals), GBL maximizes value extraction from its raw material. This diversification spreads business risk across various revenue streams and provides operational flexibility, potentially leading to better margins compared to standalone sugar mills.

Scale and Operational Efficiency: Significant crushing capacity and multiple manufacturing units can lead to economies of scale in raw material procurement, processing, and distribution.

Backward Integration and Farmer Relationships: Strong relationships with local farmers for sugarcane procurement ensure a relatively consistent and reliable supply of raw materials, which is critical in an agro-based industry.

Product Expertise in Specialty Chemicals: Developing capabilities and market access for specialty chemicals allows the company to move into higher-margin product categories compared to bulk commodities.

Growth Drivers

Government Ethanol Blending Program (EBP): India's aggressive targets for ethanol blending with petrol (E20 by 2025) provide a strong, sustained, and policy-backed demand driver for ethanol producers like GBL.

Rising Domestic Sugar Consumption: Steady population growth and increasing disposable incomes in India contribute to consistent domestic demand for sugar.

Increased Biofuel Demand: A global and national push towards renewable energy and cleaner fuels supports the demand for ethanol and other bio-products.

Value-Added Product Expansion: Further development and expansion into higher-margin specialty chemicals and derivatives can enhance profitability and diversify the revenue base.

Operational Efficiency and Capacity Expansion: Investments in modernizing facilities, optimizing processes, and expanding crushing/distillery capacities can lead to higher output and improved cost structures.

Risks

Government Regulation & Policy Changes: The sugar industry is heavily regulated in India (e.g., cane pricing, ethanol pricing, export/import policies). Adverse or frequent policy changes can significantly impact profitability and business stability.

Climatic & Agricultural Risks: High dependence on monsoon patterns and sugarcane yield makes the company vulnerable to droughts, floods, or diseases, leading to raw material shortages and price volatility.

Commodity Price Volatility: Fluctuations in global and domestic prices of sugar, ethanol, and co-generated power can directly affect revenue and profit margins.

Raw Material Availability & Pricing: Ensuring adequate and timely supply of sugarcane at competitive prices remains a continuous challenge.

Environmental Regulations: Stricter environmental norms for distilleries, sugar mills, and chemical plants can increase compliance costs and potentially impact operations.

Debt Levels: The capital-intensive nature of the sugar and biorefinery business often results in higher debt levels, making the company susceptible to interest rate fluctuations and financing costs.

Management & Ownership

Godavari Biorefineries Ltd. is likely promoted and controlled by an experienced Indian business family, which is a common structure in the Indian sugar and agro-processing sector. The management team typically comprises seasoned professionals with deep industry knowledge in sugar, chemicals, and energy sectors. Their expertise is crucial for navigating the complex regulatory environment, managing agricultural supply chains, and driving diversification efforts. Ownership is usually concentrated with the promoter group, indicating a long-term strategic vision, with a portion held by public and institutional investors.

Outlook

Godavari Biorefineries is well-positioned to capitalize on India's steady demand for sugar and the robust government impetus for ethanol blending. Its integrated bio-refinery model, diversifying revenue across sugar, ethanol, power, and specialty chemicals, provides a crucial hedge against the inherent cyclicality and price volatility of the sugar commodity market. The ambitious ethanol blending targets represent a significant and stable growth avenue for the company. However, the business faces substantial risks including the vagaries of monsoon and sugarcane production, unpredictable government policies impacting cane and product prices, and the cyclical nature of commodity markets. Sustained profitability and growth will depend on the company's ability to maintain operational efficiencies, secure consistent raw material supply, effectively manage its diversified portfolio, and adapt to evolving regulatory landscapes.

Godavari Biorefin Share Price

Live · BSE / NSE · Inception: 1956
| |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

Godavari Biorefin Quarterly Results

#(Fig in Cr.) Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Net Sales 398 615 523 321 447 580 533 431 460 564
Other Income 2 11 3 1 4 9 1 4 2 6
Total Income 400 626 525 322 451 589 534 434 462 570
Total Expenditure 353 501 535 354 411 467 527 439 417 478
Operating Profit 47 124 -9 -32 40 122 6 -4 45 92
Interest 18 20 20 20 19 13 15 12 10 11
Depreciation 16 14 13 12 12 13 13 14 14 14
Exceptional Income / Expenses 0 0 0 0 0 0 0 -27 -8 3
Profit Before Tax 13 91 -42 -64 8 96 -22 -57 13 70
Provision for Tax -26 26 -16 11 3 24 -6 -15 5 17
Profit After Tax 38 65 -26 -75 6 72 -16 -42 8 53
Adjustments 0 -0 0 -0 0 0 -0 0 0 0
Profit After Adjustments 38 65 -26 -75 6 72 -16 -42 8 53
Adjusted Earnings Per Share 9.2 15.5 -6.2 -17.9 1.1 14.1 -3.1 -8.1 1.6 10.3

Godavari Biorefin Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 964 1386 1008 1232 1552 1459 1538 1702 2015 1687 1870 1988
Other Income 4 7 7 6 14 14 8 8 8 14 17 13
Total Income 968 1393 1015 1238 1566 1473 1546 1710 2023 1701 1887 2000
Total Expenditure 920 1286 940 1128 1420 1356 1381 1569 1868 1553 1767 1861
Operating Profit 48 107 74 110 146 117 166 141 155 148 120 139
Interest 84 84 80 88 90 69 72 60 73 76 72 48
Depreciation 47 44 50 49 50 45 47 48 50 60 50 55
Exceptional Income / Expenses 0 0 -10 0 0 0 0 0 0 0 0 -32
Profit Before Tax -83 -20 -66 -27 6 3 46 32 32 12 -2 4
Provision for Tax -5 -4 -22 -8 1 -1 19 13 12 0 22 1
Profit After Tax -78 -16 -45 -19 6 4 27 19 20 12 -23 3
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments -78 -16 -45 -19 6 4 27 19 20 12 -23 3
Adjusted Earnings Per Share -21.7 -4.4 -12.1 -5.1 1.4 1 6.5 4.6 4.7 2.9 -4.6 0.7

Godavari Biorefin Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 162 143 345 337 359 427 454 473 489 501 782
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 215 230 161 139 135 123 332 328 460 355 240
Other Non-Current Liabilities 17 5 8 -6 -7 -2 6 14 26 26 49
Total Current Liabilities 840 808 918 1165 1140 871 650 919 768 1110 884
Total Liabilities 1234 1186 1432 1635 1627 1419 1442 1734 1744 1992 1955
Fixed Assets 460 468 691 745 695 735 708 667 866 850 862
Other Non-Current Assets 69 52 94 21 86 39 41 87 53 65 69
Total Current Assets 706 666 647 869 846 644 693 979 824 1077 1023
Total Assets 1234 1186 1432 1635 1627 1419 1442 1734 1744 1992 1955

Godavari Biorefin Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 9 18 12 6 4 5 5 7 10 21 11
Cash Flow from Operating Activities -69 177 30 63 287 250 130 45 197 185 6
Cash Flow from Investing Activities -51 -27 -92 -28 -55 -23 -7 -48 -214 -44 -69
Cash Flow from Financing Activities 128 -156 56 -36 -231 -226 -121 6 28 -151 64
Net Cash Inflow / Outflow 9 -6 -6 -2 1 1 2 3 11 -10 1
Closing Cash & Cash Equivalent 18 12 6 4 5 6 7 10 21 11 12

Godavari Biorefin Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) -21.73 -4.45 -12.1 -5.07 1.44 0.97 6.47 4.55 4.68 2.93 -4.58
CEPS(Rs) -8.54 7.75 1.42 7.91 14.44 11.69 17.71 16 16.62 17.22 5.21
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 45.35 40.12 93.42 89.64 93.5 101.84 108.22 112.77 116.69 119.37 152.8
Core EBITDA Margin(%) 4.39 6.96 6.34 8.33 8.51 7.08 10.25 7.81 7.26 7.92 5.54
EBIT Margin(%) 0.09 4.39 1.32 4.92 6.2 4.94 7.72 5.43 5.19 5.22 3.76
Pre Tax Margin(%) -8.34 -1.4 -6.21 -2.17 0.41 0.23 3.01 1.88 1.58 0.74 -0.08
PAT Margin (%) -7.79 -1.1 -4.19 -1.53 0.36 0.28 1.77 1.12 0.97 0.73 -1.25
Cash Profit Margin (%) -3.06 1.92 0.49 2.39 3.57 3.36 4.83 3.94 3.46 4.28 1.42
ROA(%) -6.29 -1.31 -3.42 -1.24 0.34 0.27 1.9 1.2 1.13 0.66 -1.19
ROE(%) -47.91 -10.41 -18.3 -5.59 1.59 1.03 6.16 4.12 4.08 2.48 -3.65
ROCE(%) 0.08 6.24 1.27 4.84 7.91 6.65 11.7 8.72 8.96 7.4 5.79
Receivable days 26.96 21.2 26.67 29.48 33.3 33.68 34.98 36.65 33.95 42.4 32.01
Inventory Days 194.53 128.99 169.42 165 140.59 119.09 95.69 115.34 106.13 143.32 150.75
Payable days 51.94 46.5 72 84.46 116.29 134.45 128.05 146.72 128.45 159.71 152.94
PER(x) 0 0 0 0 0 0 0 0 0 0 0
Price/Book(x) 0 0 0 0 0 0 0 0 0 0 0.96
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 0.94 0.59 0.9 0.76 0.51 0.4 0.37 0.37 0.36 0.39 0.65
EV/Core EBITDA(x) 18.77 7.69 12.2 8.51 5.42 5.01 3.39 4.48 4.74 4.48 10.05
Net Sales Growth(%) 0 43.84 -27.28 22.21 26.02 -6 5.42 10.67 18.35 -16.28 10.88
EBIT Growth(%) 0 6907.81 -77.8 336.01 56.92 -25.18 64.8 -22.07 13.01 -15.81 -20.18
PAT Growth(%) 0 79.52 -181.19 57.32 129 -26.57 568.35 -29.67 2.83 -37.37 -290.39
EPS Growth(%) 0 79.52 -171.95 58.1 128.44 -32.81 568.35 -29.67 2.83 -37.37 -256.04
Debt/Equity(x) 5.57 5.74 2.63 2.8 2.21 1.38 1.23 1.34 1.5 1.31 0.63
Current Ratio(x) 0.84 0.82 0.7 0.75 0.74 0.74 1.07 1.07 1.07 0.97 1.16
Quick Ratio(x) 0.21 0.22 0.16 0.21 0.24 0.3 0.41 0.36 0.4 0.24 0.32
Interest Cover(x) 0.01 0.76 0.18 0.69 1.07 1.05 1.64 1.53 1.44 1.16 0.98
Total Debt/Mcap(x) 0 0 0 0 0 0 0 0 0 0 0.65

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +11% +3% +5% +7%
Operating Profit CAGR -19% -5% +1% +10%
PAT CAGR -292% 0% 0%
Share Price CAGR -6%
ROE Average -4% +1% +3% -6%
ROCE Average +6% +7% +9% +6%

Godavari Biorefin Shareholding Pattern

Latest · Mar 2026
100% held
Promoters 63.31 %
FII 0.98 %
DII (MF + Insurance) 10.39 %
Public (retail) 36.69 %
# Mar 2015 Mar 2016 Sep 2017 Sep 2018 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 76.8376.8377.2377.4463.3163.3163.3163.3163.3163.31
FII 00001.140.970.630.60.860.98
DII 13.3313.3313.3313.0914.8814.1713.9811.9811.1610.39
Public 23.1723.1722.7722.5636.6936.6936.6936.6936.6936.69
Others 0000000000
Total 100100100100100100100100100100

Godavari Biorefin Peer Comparison

Godavari Biorefin Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Godavari Biorefin Pros & Cons

Pros

  • Debtor days have improved from 159.71 to 152.94days.
  • Company has reduced debt.

Cons

  • Company has a low return on equity of 1% over the last 3 years.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp